French study maps scalp ringworm fungi and drug resistance
NCT ID NCT07631351
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at scalp ringworm, a common fungal infection in children, across 11 French centers in 2023. Researchers collected 701 fungal samples to identify the species and test their sensitivity to common antifungal drugs. The goal was to understand which fungi cause infections and whether resistance to treatments like terbinafine is emerging, helping guide future treatment choices.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors choose better treatments for scalp ringworm in children by understanding which fungi are common and whether they resist current drugs.
- What could go wrong
- This is an observational study, not a treatment trial. It describes the problem but does not test a new therapy, so direct patient benefits are not guaranteed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
701 people
The number who actually took part.
- Started
-
Jan 2023
- Finished
-
Dec 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with tinea capitis (TC) in France
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All dermatophyte isolates obtained from scalp sample cultures in the 11 centers between January 2, 2023, and December 31, 2023, Exclusion Criteria: \-
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Isolates of dermatophytes are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Parasitology-Mycology Department, Avicenne Hospital AP-HP,
Bobigny, Seine Saint Denis, 93009, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.